EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹681 Cr | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹681 Cr |
| Mar2025 | ₹498 Cr |
| Mar2024 | ₹532 Cr |
| Mar2023 | ₹662 Cr |
| Mar2022 | ₹392 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹681 Cr | 36.76 | |
| Mar2025 | ₹498 Cr | -6.36 | |
| Mar2024 | ₹532 Cr | -19.66 | |
| Mar2023 | ₹662 Cr | 68.87 | |
| Mar2022 | ₹392 Cr | - | |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,809.0 Cr | -5.4% | -4.6% | 38.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -5.4% |
-4.6% |
38.1% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses